These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 33106477)

  • 1. Targeting SKA3 suppresses the proliferation and chemoresistance of laryngeal squamous cell carcinoma via impairing PLK1-AKT axis-mediated glycolysis.
    Gao W; Zhang Y; Luo H; Niu M; Zheng X; Hu W; Cui J; Xue X; Bo Y; Dai F; Lu Y; Yang D; Guo Y; Guo H; Li H; Zhang Y; Yang T; Li L; Zhang L; Hou R; Wen S; An C; Ma T; Jin L; Xu W; Wu Y
    Cell Death Dis; 2020 Oct; 11(10):919. PubMed ID: 33106477
    [TBL] [Abstract][Full Text] [Related]  

  • 2. circPARD3 drives malignant progression and chemoresistance of laryngeal squamous cell carcinoma by inhibiting autophagy through the PRKCI-Akt-mTOR pathway.
    Gao W; Guo H; Niu M; Zheng X; Zhang Y; Xue X; Bo Y; Guan X; Li Z; Guo Y; He L; Zhang Y; Li L; Cao J; Wu Y
    Mol Cancer; 2020 Nov; 19(1):166. PubMed ID: 33234130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circular RNA circCORO1C promotes laryngeal squamous cell carcinoma progression by modulating the let-7c-5p/PBX3 axis.
    Wu Y; Zhang Y; Zheng X; Dai F; Lu Y; Dai L; Niu M; Guo H; Li W; Xue X; Bo Y; Guo Y; Qin J; Qin Y; Liu H; Zhang Y; Yang T; Li L; Zhang L; Hou R; Wen S; An C; Li H; Xu W; Gao W
    Mol Cancer; 2020 Jun; 19(1):99. PubMed ID: 32487167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PDK1 signaling toward PLK1-MYC activation confers oncogenic transformation, tumor-initiating cell activation, and resistance to mTOR-targeted therapy.
    Tan J; Li Z; Lee PL; Guan P; Aau MY; Lee ST; Feng M; Lim CZ; Lee EY; Wee ZN; Lim YC; Karuturi RK; Yu Q
    Cancer Discov; 2013 Oct; 3(10):1156-71. PubMed ID: 23887393
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SKA3 promotes glioblastoma proliferation and invasion by enhancing the activation of Wnt/β-catenin signaling via modulation of the Akt/GSK-3β axis.
    Li C; Yang J; Lei S; Wang W
    Brain Res; 2021 Aug; 1765():147500. PubMed ID: 33895155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SKA3 promotes lung adenocarcinoma metastasis through the EGFR-PI3K-Akt axis.
    Hu DD; Chen HL; Lou LM; Zhang H; Yang GL
    Biosci Rep; 2020 Feb; 40(2):. PubMed ID: 32068236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miR-1207-5p suppresses laryngeal squamous cell carcinoma progression by downregulating SKA3 and inhibiting epithelial-mesenchymal transition.
    Wu Y; Dai F; Zhang Y; Zheng X; Li L; Zhang Y; Cao J; Gao W
    Mol Ther Oncolytics; 2021 Sep; 22():152-165. PubMed ID: 34514096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ribophorin II promotes the epithelial-mesenchymal transition and aerobic glycolysis of laryngeal squamous cell carcinoma via regulating reactive oxygen species-mediated Phosphatidylinositol-3-Kinase/Protein Kinase B activation.
    Zhou J; Zhang J; Zhang W; Ke Z; Lv Y; Zhang B; Liao Z
    Bioengineered; 2022 Mar; 13(3):5141-5151. PubMed ID: 35156537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of cell apoptosis and proliferation in pancreatic cancer through PI3K/Akt pathway via Polo-like kinase 1.
    Mao Y; Xi L; Li Q; Cai Z; Lai Y; Zhang X; Yu C
    Oncol Rep; 2016 Jul; 36(1):49-56. PubMed ID: 27220401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low-dose arsenic-mediated metabolic shift is associated with activation of Polo-like kinase 1 (Plk1).
    Li Z; Lu Y; Ahmad N; Strebhardt K; Liu X
    Cell Cycle; 2015; 14(19):3030-9. PubMed ID: 26292025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SKA3 Promotes Cell Growth in Breast Cancer by Inhibiting PLK-1 Protein Degradation.
    Ruan LW; Li PP; Jin LP
    Technol Cancer Res Treat; 2020; 19():1533033820947488. PubMed ID: 32799774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutations of the LIM protein AJUBA mediate sensitivity of head and neck squamous cell carcinoma to treatment with cell-cycle inhibitors.
    Zhang M; Singh R; Peng S; Mazumdar T; Sambandam V; Shen L; Tong P; Li L; Kalu NN; Pickering CR; Frederick M; Myers JN; Wang J; Johnson FM
    Cancer Lett; 2017 Apr; 392():71-82. PubMed ID: 28126323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Polo-like kinase 1 inhibitor onvansertib represents a relevant treatment for head and neck squamous cell carcinoma resistant to cisplatin and radiotherapy.
    Hagege A; Ambrosetti D; Boyer J; Bozec A; Doyen J; Chamorey E; He X; Bourget I; Rousset J; Saada E; Rastoin O; Parola J; Luciano F; Cao Y; Pagès G; Dufies M
    Theranostics; 2021; 11(19):9571-9586. PubMed ID: 34646387
    [No Abstract]   [Full Text] [Related]  

  • 14. Upregulation of SKA3 enhances cell proliferation and correlates with poor prognosis in hepatocellular carcinoma.
    Tang J; Liu J; Li J; Liang Z; Zeng K; Li H; Zhao Z; Zhou L; Jiang N
    Oncol Rep; 2021 Apr; 45(4):. PubMed ID: 33760206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of spindle and kinetochore associated complex subunit 3 suppresses the proliferation and invasion and induced the apoptosis of cutaneous melanoma by affecting the PI3K/Akt pathway.
    Liang Y; Zheng Y; Mou K; Han D; Wang L; Ge R; Meng A
    J Biochem Mol Toxicol; 2021 Nov; 35(11):e22895. PubMed ID: 34423490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aberrant methylation-mediated downregulation of lncRNA SSTR5-AS1 promotes progression and metastasis of laryngeal squamous cell carcinoma.
    Wang B; Zhao L; Chi W; Cao H; Cui W; Meng W
    Epigenetics Chromatin; 2019 Jun; 12(1):35. PubMed ID: 31196171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contribution of TIP30 to chemoresistance in laryngeal carcinoma.
    Zhu M; Yin F; Yang L; Chen S; Chen R; Zhou X; Jing W; Fan X; Jia R; Wang H; Zheng H; Zhao J; Guo Y
    Cell Death Dis; 2014 Oct; 5(10):e1468. PubMed ID: 25321475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of iASPP on chemoresistance through PLK1 and autophagy in ovarian clear cell carcinoma.
    Chan KK; Wong OG; Wong ES; Chan KK; Ip PP; Tse KY; Cheung AN
    Int J Cancer; 2018 Sep; 143(6):1456-1469. PubMed ID: 29663364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plumbagin inhibits the proliferation and survival of esophageal cancer cells by blocking STAT3-PLK1-AKT signaling.
    Cao YY; Yu J; Liu TT; Yang KX; Yang LY; Chen Q; Shi F; Hao JJ; Cai Y; Wang MR; Lu WH; Zhang Y
    Cell Death Dis; 2018 Jan; 9(2):17. PubMed ID: 29339720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spindle and kinetochore-associated complex 3 promotes cell growth via the PI3K/AKT/GSK3β and PI3K/AKT/FOXO1 pathways and is a potential prognostic biomarker for oral squamous cell carcinoma.
    Xu H; Chen G; Niu Q; Song K; Feng Z; Han Z
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2022 Nov; 134(5):599-614. PubMed ID: 36123287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.